Luc Gagnon, vice president of vaccine sciences at Nexelis, gives an insight into the increase in vaccine hesitancy and the role that pharmaceutical and R&D industries need to take to address the problem.
The rise of an anti-vaccination sentiment
Vaccinations have been a key innovation from the health industry in safeguarding us from previously serious and deadly diseases, protecting us in new ways to major public health threats. Vaccines represent a landmark shift from treatment to prevention, saving countless lives and improving the health and life expectancy of millions around the world.